(Q44841721)

6 December 2017

title

Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids (English)

1 reference

Mycobacterium tuberculosis

6 December 2017

main subject

0 references

author

Andrea Scozzafava

series ordinal

3

1 reference

6 December 2017

5

Claudiu T Supuran

1 reference

6 December 2017

Alfonso Maresca

1

1 reference

6 December 2017

Daniela Vullo

series ordinal

2

1 reference

6 December 2017

Gheorghe Manole

series ordinal

4

1 reference

6 December 2017

publication date

3 February 2012

1 reference

Journal of Enzyme Inhibition and Medicinal Chemistry

6 December 2017

published in

1 reference

6 December 2017

volume

28

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

392-396

1 reference

Enhancement of the antituberculosis activity of weak acids by inhibitors of energy metabolism but not by anaerobiosis suggests that weak acids act differently from the front-line tuberculosis drug pyrazinamide

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Interfering with pH regulation in tumours as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Carbonic anhydrases: current state of the art, therapeutic applications and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Carbonic anhydrase inhibitors and activators for novel therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Binding affinity of bicarboxylate ions for cobalt (II) bovine carbonic anhydrase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Structure and function of carbonic anhydrases from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Structural mechanics of the pH-dependent activity of beta-carbonic anhydrase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

The β-carbonic anhydrases from Mycobacterium tuberculosis as drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Brucella carbonic anhydrases: new targets for designing anti-infective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Carbonic anhydrase inhibition with natural products: novel chemotypes and inhibition mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Emerging drugs for active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Recent advances in antituberculous drug development and novel drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Characterization and inhibition studies of an α-carbonic anhydrase from the endangered sturgeon species Acipenser gueldenstaedti.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Genes required for mycobacterial growth defined by high density mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Interaction of cobalt-bovine carbonic anhydrase with the acetate ion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.650168

10.3109/14756366.2011.650168

21 January 2018

Identifiers

DOI

1 reference

release_b7owvn2ywzbqtonihq2rcd2dka

6 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b7owvn2ywzbqtonihq2rcd2dka

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference